In 2019, however, the agency approved a prescription version of ketamine, a nasal spray known as esketamine (or Spravato), ...

A watershed moment came in March when the U.S. Food and Drug Administration (FDA) approved Spravato, or esketamine, a ketamine nasal spray for adults with treatment-resistant major depression.

Ketamine has a reputation as a party drug but is licensed as an anaesthetic. The study found use of the drug via a nasal spray led to "significant" improvements in depressive symptoms in the first ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato ... The drug is the first ketamine-based medicine approved to treat depression. Ketamine has long been seen as a potential ...

The FDA added a warning to the label of esketamine nasal spray (Spravato), noting that long-term cognitive and memory ...

Using an old anesthesia drug to pull people out of the depths of severe depression has gone from fringe idea to widespread use in just a few years. Sparked by promising studies and stories of ...

Right now Ketamine is not FDA approved to treat any psychiatric disorder. But back inJuly, Johnson and Johnson did seek approval for a nasal Ketamine spray, that is currently in waiting.

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

A new tablet form of ketamine has shown promise in treating ... led by Weill Cornell Medicine investigators showed that a nasal spray that patients administer at home, without a physician ...